Seven out of the 17 analysts have a "buy" rating on BHEL, while eight of them still have a "sell" recommendation. Two others have a "hold" rating.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback